<bill session="116" type="s" number="4640" updated="2023-01-11T13:44:44Z">
  <state datetime="2020-09-22">REFERRED</state>
  <status>
    <introduced datetime="2020-09-22"/>
  </status>
  <introduced datetime="2020-09-22"/>
  <titles>
    <title type="display">MATE Act of 2020</title>
    <title type="short" as="introduced">MATE Act of 2020</title>
    <title type="short" as="introduced">Medication Access and Training Expansion Act of 2020</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to require physicians and other prescribers of controlled substances to complete training on treating and managing patients with opioid and other substance use disorders, which shall also satisfy certain training requirements to receive a waiver for dispensing narcotic drugs for maintenance or detoxification treatment, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001267"/>
  <cosponsors>
    <cosponsor bioguide_id="C001035" joined="2020-09-22"/>
  </cosponsors>
  <actions>
    <action datetime="2020-09-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2020-09-22" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="4974" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-22T23:04:56Z" status="Introduced in Senate">Medication Access and Training Expansion Act of 2020 or the MATE Act of 2020

This bill requires prescribers of controlled substances, as a condition of obtaining or renewing their registration with the Drug Enforcement Administration, to complete specified education or training on the prevention, treatment, and management of opioid-use and other substance-use disorders. This education and training shall also satisfy the training requirements currently needed to obtain waivers to prescribe certain medication-assisted treatments for opioid-use disorders in settings other than opioid treatment programs.</summary>
</bill>
